- Home
- CRDF vs NIU Comparison
CRDF vs NIU Comparison
Compare CRDF & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- NIU
- Stock Information
- Founded
- CRDF 1999
- NIU 2014
- Country
- CRDF United States
- NIU China
- Employees
- CRDF N/A
- NIU N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- NIU Auto Manufacturing
- Sector
- CRDF Health Care
- NIU Consumer Discretionary
- Exchange
- CRDF Nasdaq
- NIU Nasdaq
- Market Cap
- CRDF 233.5M
- NIU 216.7M
- IPO Year
- CRDF N/A
- NIU 2018
- Fundamental
- Price
- CRDF $4.04
- NIU $3.39
- Analyst Decision
- CRDF Strong Buy
- NIU
- Analyst Count
- CRDF 6
- NIU 0
- Target Price
- CRDF $11.92
- NIU N/A
- AVG Volume (30 Days)
- CRDF 1.4M
- NIU 1.1M
- Earning Date
- CRDF 08-07-2025
- NIU 08-11-2025
- Dividend Yield
- CRDF N/A
- NIU N/A
- EPS Growth
- CRDF N/A
- NIU N/A
- EPS
- CRDF N/A
- NIU N/A
- Revenue
- CRDF $587,000.00
- NIU $477,578,753.00
- Revenue This Year
- CRDF N/A
- NIU $41.32
- Revenue Next Year
- CRDF N/A
- NIU $24.38
- P/E Ratio
- CRDF N/A
- NIU N/A
- Revenue Growth
- CRDF N/A
- NIU 26.51
- 52 Week Low
- CRDF $2.01
- NIU $1.66
- 52 Week High
- CRDF $5.64
- NIU $4.90
- Technical
- Relative Strength Index (RSI)
- CRDF 65.93
- NIU 49.38
- Support Level
- CRDF $3.07
- NIU $3.42
- Resistance Level
- CRDF $4.22
- NIU $3.69
- Average True Range (ATR)
- CRDF 0.22
- NIU 0.18
- MACD
- CRDF 0.08
- NIU 0.00
- Stochastic Oscillator
- CRDF 87.35
- NIU 31.63
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.